" class="no-js "lang="en-US"> Aster Insights - Medtech Alert
Thursday, March 28, 2024
Aster Insights | MTA

Aster Insights

About Aster Insights

Aster Insights
Aster Insights is a leading oncology-focused bioinformatics solutions company advancing precision medicine and transforming cancer care through clinical and molecular data and analytics tools. The company's innovative dataset accelerates the discovery, development, and delivery of personalized therapies. Aster Insights is the only bioinformatics company that has lifetime, patient-consented longitudinal clinical data, coupled with whole exome (WES) and whole transcriptome (WTS) sequencing, for both tumor and germline data. Aster Insight's Oncology Research Information Exchange Network® (ORIEN), an alliance of NCI-Designated cancer centers that gather de-identified and lifetime-consented clinical and genomic patient data for research purposes, enables a collaborative approach to medical product discovery.

Related Story

M2GEN Rebrands to Aster Insights

April 14 2023

M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomic data to accelerate medical […]

M2GEN Expands World-Class Executive Leadership Team Appoints Melissa Honour, MPH, as Chief Product Officer

July 14 2022

M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, today announced […]